GVDBF News and Press, Givaudan AG From 07/21/20

Givaudan SA (GVDBF) Q2 2020 Earnings Conference Call July 21, 2020, 09:00 AM ET Company Participants Gilles Andrier - Chief Executive Officer Tom Hallam - Chief Financial Officer Conference Call Participants Celine Pannuti - JPM Heidi Vesterinen - Exane Paribas Patrick Ra...

The following slide deck was published by Givaudan SA in conjunction with their 2020 Q2 earnings Read more ...

Givaudan SA ( OTCPK:GVDBF ) : 1H GAAP EPS of CHF44.81. More news on: Givaudan SA, Givaudan SA, Earnings news and commentary, Read more ...

Source: ClearBridge Investments Editor's Note: The summary bullets for this article were chosen by Seeking Alpha Read more ...

Source : ClearBridge Investments Editor's Note : The summary bullets for this article were chosen by Read more ...

Koninklijke DSM is among suitors exploring potential bids for DuPont's ( DD -0.5% ) nutrition and bioscience business, which could be valued at as much as $25B, Bloomberg reports. More news on: DuPont de Nemours, Inc., Koninklijke DSM N.V., Kerry Group plc, Merger & acquisition new...

DuPont ( DD +3.8% ) is considering unloading its nutrition and biosciences division , and is working with advisers to evaluate options that could include selling or spinning off the business, Bloomberg reports. More news on: DuPont de Nemours, Inc., International Flavors & Fragrance...

Thesis summary I believe that Lonza (LZAGF) is a great business that is underappreciated by the market due to its high business complexity, but strong growth should continue on the back of synergies, several global megatrends, and focus on the company's healthcare continuum. Also, the comp...

Givaudan SA (GVDBF) Q2 2019 Earnings Conference Call July 18, 2019 09:00 AM ET Company Participants Gilles Andrier - Chief Executive Officer Tom Hallam - Chief Financial Officer Conference Call Participants Patrick Rafaisz - UBS Celine Pannuti - JP Morgan Theodora Joseph ...

The following slide deck was published by Givaudan SA in conjunction with their 2019 Q2 earnings Read more ...